MedPath

Effects of GnRH agonist for luteal support on improvement of IVF/ICSI cycles

Phase 2
Conditions
Complication associated with artificial fertilization, unspecified
oninflammatory disorders of female genital tract.
Registration Number
IRCT20160722029027N6
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
240
Inclusion Criteria

Age between 20-38 years old
Body mass index (BMI) between 20-30
Fresh embryo transfer cycles
3rd menstrual day serum FSH below 10
Absence of low ovarian response according Bologna Criteria

Exclusion Criteria

Unwillingness to continue
Absence of good quality embryo
Ovarian hyper stimulation (more than 18 mature follicle during ovarian stimulation)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG.
Secondary Outcome Measures
NameTimeMethod
Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation.
© Copyright 2025. All Rights Reserved by MedPath